Budget impact analysis of enzalutamide for treatment of metastatic castration-resistant prostate cancer from a u.s. Payer perspective
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1135
https://www.valueinhealthjournal.com/article/S1098-3015(15)01192-4/fulltext
Title :
Budget impact analysis of enzalutamide for treatment of metastatic castration-resistant prostate cancer from a u.s. Payer perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01192-4&doi=10.1016/j.jval.2015.03.1135
First page :
A196
Section Title :
Cancer
Open access? :
No
Section Order :
591